Search
for
Sort by
Research 391–420 of 1000+
- Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Immunization and Bacterial Pathogens in the Oropharynx as Risk Factors for Alopecia Areata
- Lichen planopilaris in men: a retrospective clinicopathologic study of 19 patients
- Stressful lie events in alopecia areata patients: A case control study
- Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies
- Fibrosing Alopecia in a Pattern Distribution
- Folliculitis decalvans: A multicenter review of 82 patients
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- Epidemiology and burden of alopecia areata in Taiwan: a systematic review
- Life Events Preceding Alopecia Areata Onset—a Descriptive Retrospective Cohort Study Focusing on Strain
- Association between SQSTM1 dysregulation and risk in alopecia areata: a Mendelian randomization study
- Primary cutaneous follicle center lymphoma presenting as frontal fibrosing alopecia
- Th1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Activation of the integrated stress response in human hair follicles
- Peroxisome Proliferator Activated Receptors Gamma Serum levels and Gene Polymorphism in Frontal Fibrosing Alopecia: A Case Control Study
- Immunohistochemistry study of pentoxifylline in the treatment of alopecia induced by cyclophosphamide in male rats
- Lichen‐planopilaris‐like scarring pattern in a patient with alopecia and pityriasis rubra pilaris
- 1365 Interest of Biotrinine®, a mix of Nasturtium officinale and Tropaeolum majus extracts, for chronic hair loss treatment
- 490 Samcyprone (diphenylcyclopropenone ointment) for the treatment of common warts
- Contents Vol. 4, 2018
- Alopecia areata: An update
- Plasma Rich in Growth Factors as an Adjuvant Treatment for the Management of Frontal Fibrosing Alopecia: A Retrospective Observational Clinical Study
- Novel drugs of United States Food and Drug Administration approved in 2024
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Modern Management Approaches for Alopecia Areata
- Is There an Association Between Male Alopecia Areata and the Ratio of Second to Fourth Finger Length?
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Biology and Genetics of Hair